Sleep loss in Alzheimer’s is caused by immune cells, not plaques
Poor sleep in Alzheimer’s has long been blamed on the brain plaques that define the disease. A new mouse study flips that assumption: the brain’s own immune cells, not the plaques themselves, appear to drive the sleep loss.
Microglia are the brain’s immune cells. In Alzheimer’s, they respond to amyloid plaques by staying chronically active and releasing inflammatory signals. The researchers investigated what happens to sleep when most of these microglia are temporarily removed in mice with brain plaques. The result was striking: the mice slept more than two hours longer per day, even though the plaques remained unchanged.
Plaques are not the direct cause
This finding suggests that sleep disruption in Alzheimer’s may not be caused directly by the plaques, but by the inflammatory response that microglia mount against them. The microglia appear to keep the brain in a state of heightened alertness that prevents deep, restorative sleep. That distinction matters, because many current Alzheimer’s therapies focus on clearing plaques. Improving sleep may require a different target.
The study was conducted in mice, so results are preliminary and cannot be directly translated to humans. Still, it points to microglial activity as an independent target for addressing sleep problems in Alzheimer’s.
Sleep as a longevity factor
Sleep is one of the most robustly supported factors in aging research. Chronic sleep deprivation accelerates cognitive decline and raises the risk of neurodegeneration. If overactive microglia drive that sleep loss, targeting the inflammatory response rather than the plaques could open a new therapeutic avenue. Whether a comparable mechanism operates in humans remains to be established.
Want to research this yourself?
Search for example:
- microglia neuroinflammation sleep
- amyloid plaques sleep regulation
- deep sleep neurodegeneration